Saudi Healthcare Transformation Under Vision 2030: A Global Model For Innovation In Biotherapy

Dr. Majid Al-Fayyad, CEO of King Faisal Specialist Hospital and Research Centre (KFSHRC), highlighted the Kingdom's healthcare transformation as a key aspect of Vision 2030. This transformation is positioning Saudi Arabia as a global leader in resilient and innovative healthcare systems. He shared these insights at the Future of Health Summit by the Milken Institute in Washington, D.C.

Al-Fayyad emphasised that Saudi Arabia is making significant strides in gene therapy and stem cells. The nation aims to become a hub for advanced biotherapies. During a session on innovation in gene-editing therapies, he noted the Kingdom's dedication to sustainable innovation and its readiness to lead genomic medicine advancements.

KFSHRC has developed T-cell therapy locally, which has shown effectiveness in treating advanced cancer cases. This development also achieved an 80% reduction in costs. Such progress highlights how local biomanufacturing can improve treatment access and affordability across the region.

The Saudi Food and Drug Authority plays a crucial role by creating a supportive regulatory environment. It has streamlined clinical approval processes, aligning them with international standards. This ensures patients gain quicker access to innovative treatments.

KFSHRC is at the forefront of clinical trials in Saudi Arabia, leading nearly half of them. This effort strengthens the national research system, turning scientific discoveries into real medical solutions. Al-Fayyad stated that this approach enhances the Kingdom's healthcare capabilities significantly.

Looking forward, KFSHRC plans to establish the first national biofabrication facility. This facility aims to meet 9% of the country's demand for gene and cell therapies by 2030, potentially saving SAR8 billion. It represents a strategic investment in localising medical technologies and fostering global partnerships.

Future Prospects

This initiative will bolster biotechnology and precision medicine advancement within Saudi Arabia. By building necessary infrastructure, it supports international collaborations, driving further progress in these fields.

The ongoing transformation within Saudi Arabia's healthcare sector underscores its commitment to becoming a model for innovation-driven systems worldwide. Through strategic investments and regulatory support, the Kingdom is paving the way for future advancements in healthcare.

With inputs from SPA